The featured leaders list highlights influential voices across biotechnology, pharmaceutical innovation, translational science, clinical development, regulation, manufacturing readiness, investment, and commercial strategy. Participation remains open conference — you cannot register directly unless your proposal or eligibility is accepted through the review workflow.
Accepted presenters register after review; non-presenting delegates may register directly.
participation@executivecongresses.com
Keynote sessions and expert discussions connect scientific research, translation, manufacturing, regulation, investment, innovation and industry collaboration.
Meet the current keynote speaker group for EICBPI 2027. Researchers, academics, clinicians, professionals and industry participants are welcome to attend the conference.
University of York, United Kingdom
Perspectives on biotechnology translation, therapeutic development, and research-to-application pathways.
University of Birmingham, United Kingdom
Strategic insight into genetic resources, resilience science, and biotechnology applications for future health and food systems.
National University of Ireland, Ireland
Research leadership across molecular inflammation, therapeutic targets, and translational pharmaceutical innovation.
Technical University of Munich, Germany
Perspectives on cellular systems, disease modelling, and biotechnology routes from laboratory research to applied innovation.
Brunel University London, United Kingdom
Insight into neurogenetic research, molecular disease pathways, and emerging therapeutic opportunities.
University of Luxembourg
Discussion on cytokine signalling, translational immunology, and precision therapeutic development.
Saarland University, Germany
Strategic perspectives on epigenomics, systems-level biology, and advanced biotechnology applications.
Biotechnology Research Institute, CAAS, China
Leadership insight into agricultural biotechnology, applied bioinnovation, and scalable research impact.
The Ohio State University, USA
Focused perspectives on biotechnology process strategy, collaborative innovation, and industry-ready development pathways.
Vilnius University, Lithuania
Insight into molecular biotechnology tools, epigenetic mechanisms, and platform technologies for research and therapeutics.
Environmental Biotechnology, Germany
Strategic discussion on environmental biotechnology, bioresource recovery, and sustainable biotechnology systems.
University of Ghent, Belgium
Perspectives on genomics, pharmaceutical biotechnology, and applied molecular innovation in regulated environments.
